Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56.
Published February 13, 2013 · Recall initiated: November 8, 2012
Summary
FDA records drug Class I recall D-153-2013, published February 13, 2013 and initiated November 8, 2012. Recalling firm: Hospira Inc.; Status: Completed; Reported quantity: 23,315 vials; Lot: Lot #: Z021650AA, Exp. 08/2013. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARBOPLATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARBOPLATIN
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot #: Z021650AA, Exp. 08/2013
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, ForFebruary 13, 2013
- FDASyeda (drospirenone and ethinyl estradiol), 3 mg/0.03 mg, 3 x 28 tablet blistercards, combination oralFebruary 13, 2013
- FDAESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant Moisturizer Broad SpectrumFebruary 13, 2013
- FDAZicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle,February 13, 2013
- FDACarboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only, antineoplastic/cytotoxic agent; ManufacturedSeptember 26, 2012
- FDACarboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS), b)August 22, 2012
Questions about this recall
Was Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56. recalled?
Yes. FDA published recall D-153-2013 on February 13, 2013. Reported hazard: Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARBOPLATIN.